Industry Trend Report|New Drugs: Exosome Development Opportunities
Exosomes have become a new favorite in the pharmaceutical industry Exosomes are small vesicles (extracellular vesicles) that are secreted outward by cells. ... Read more
Exosomes have become a new favorite in the pharmaceutical industry Exosomes are small vesicles (extracellular vesicles) that are secreted outward by cells. ... Read more
3. How can emerging therapies turn the corner in the post-pandemic era? Can Taiwan...Cell Therapy or Gene Therapy Breakthroughs, conquests and cures are the key to human beings facing diseases and challenging life's ... Read more
2. Technology companies are actively involved in the medical and biotechnology fields, how can they demonstrate their performance on the ground? As shown in Figure 2, the global medical technology (MedTech) market in 2021 is expected to grow at an annualized rate of 1.2% to 1.2%. ... Read more
With the breakthroughs in human science and the rapid development of technology, the concept of human beings on diseases has been shifted from disease treatment to disease prevention, and the medical treatment options have also been shifted from the closed and conservative in the past to the multi-disciplinary approach. ... Read more
Large Foreign Companies Developing Surgical and Online Digital Therapies Together According to the list of FDA-approved VR/AR medical devices (Table 1), there are currently several ... Read more
How powerful is Metaverse in the medical field? The technological innovations carried out by Metaverse are quietly promoting a subversive reform of the medical industry ~~~ Metaverse is ... Read more
The full name of CDMO is Contract Development and Manufacturing Organiza ... Read more
A COVID-19 event has created CDMO fever in the global biotech industry. In order to seize the market opportunity which can reach US$242.64 billion by 2026, CDMO ... Read more
In recent years, there have been a number of small molecule peptide research and development companies in China, ranging from upstream APIs such as ScinoPharm and Jianyi Biotech, to new drug development companies such as Quanfu and Taiwan Microsystems. ... Read more
International Ophthalmology Companies Positioned in Gene Therapy As the policies of Europe and the United States in recent years have encouraged the development of rare disease drugs, which are entitled to a tax deduction for trial expenses and an exclusivity period of 7-10 years, coupled with the fact that the rare disease drug ... Read more